PRODUCTS
Developed and manufactured by TETEC AG, part of Octane Medical Group, NOVOCART products use a patient’s own cartilage cells to treat focal cartilage defects in the knee.
NOVOCART Inject combines a patient’s own cartilage cells with an injectable hydrogel to treat focal cartilage defects in the knee.
Hydrogel sets within approximately 1–3 minutes
Transplantation can be performed arthroscopically in suitable patients.
In clinical use since 2008
NOVOCART 3D is a personalized cell therapy for focal cartilage defects in the knee. The transplanted cells support cartilage regeneration.
Collagen-based scaffold seeded with a patient’s own cartilage cells
Transplantation via a small surgical approach (mini-arthrotomy)
In clinical use since 2003
SINCE 2003
TETEC-manufactured cell transplants have been used in more than 30,000 cartilage repair procedures in Germany.
From global scientific societies to leading academic and industry partners, TETEC is recognized and trusted by organizations advancing the future of cartilage repair.
At our Reutlingen facility in Germany, TETEC manufactures each transplant for an individual patient using closed isolator systems within a controlled cleanroom environment.
Every transplant remains identifiable and traceable throughout manufacturing. Before release, each undergoes testing for sterility, cell viability, and cartilage-specific gene expression.
